The Melanoma Research Foundation (MRF) met on November 15, 2010 with high-level officials at the Food and Drug Administration (FDA), including Dr. Richard Pazdur, the Direc...

The U.S Food and Drug Administration (FDA) extended its deadline for an approval decision on Bristol-Myers Squibb’s (BMS) drug for advanced melanoma, ipilimumab. ...

[jwplayer |config=mrfplayer | file=https://melaresearcstg.wpengine.com/sites/default/files/upload/VTS_01_1.flv | image=https://melaresearcstg.wpengine.com/sites/default/fil...

MRF will be hosting a Capitol Hill briefing to discuss the current controversies around indoor tanning and skin cancer with Representatives Carolyn B. Maloney (D-NY), Charl...

The National Council on Skin Cancer Prevention (NCSCP) asks patients to submit comments in advance of a FDA hearing to review current classification or regulatory controls ...